Results 191 to 200 of about 2,115,183 (392)

Felbamate as an add-on therapy for refractory partial epilepsy. [PDF]

Cochrane Database Syst Rev, 2017
Shi LL, Dong J, Ni H, Geng J, Wu T.
europepmc   +1 more source

A randomized, double-blind, double-dummy, multicenter trial comparing the efficacy and safety of extended- and immediate-release levetiracetam in people with partial epilepsy [PDF]

, 2018
Tony Wu, Siew‐Na Lim, Jing-Jane Tsai, Yao‐Chung Chuang, Chin‐Wei Huang, Chun-Chieh Lin, Chang-Hung Hsu, Hong-Chung Fung, Chih‐Hong Lee   +8 more
openalex   +1 more source

Disease Progression in Multiple System Atrophy: The ASPIRE Multi‐Modal Biomarker Study

Annals of Neurology, EarlyView.
Objective The objective of this study was to characterize changes in candidate biomarkers in early multiple system atrophy (MSA) and identify baseline predictors of faster progression. Methods This 1‐year, multicenter, prospective study assessed clinical, neuroimaging (3T‐magnetic resonance imaging [MRI], dopamine transporter single‐photon emission ...
Margherita Fabbri, Natalia del Campo, Wassilios G. Meissner, Vanessa Rousseau, Agnès Sommet, Pierre Payoux, Pierre Gantet, Amel Drif, Hélène Catalá, Claire Thalamas, Christine Tranchant, Franck Durif, Ana Marques, Alexandre Eusebio, Luc Defebvre, Jean‐Christophe Corvol, Stéphane Thobois, Anthime Flaus, Anne‐Gaelle Corbille, Solène Frismand, Beverley Patterson, Alexandra Foubert‐Samier, Anne Pavy‐Le Traon, Germain Arribarat, Patrice Péran, Olivier Rascol, for the ASPIRE Study Group   +26 more
wiley   +1 more source

Pharmacoeconomic analysis of adjuvant use of zonisamide therapy resistant partial epilepsy in adults

Качественная клиническая практика, 2018
The purpose of pharmacoeconomic studies of the drug zonisamide is to determine it’s clinical and cost-effectiveness in adult patients with refractory partial epilepsy in comparison with other new antiepileptic drugs in the conditions of the Russian ...
D. Yu. Belousov, E. V. Afanasyeva, E. A. Efremova   +2 more
doaj  

Adjunctive zonisamide therapy in the long‐term treatment of children with partial epilepsy: Results of an open‐label extension study of a phase III, randomized, double‐blind, placebo‐controlled trial

Epilepsia, 2014
R. Guerrini, A. Rosati, Kate Bradshaw, L. Giorgi   +3 more
semanticscholar   +1 more source

Trametinib in Adults with Neurofibromatosis Type 1‐Related Symptomatic Plexiform Neurofibromas

Annals of Neurology, EarlyView.
Objective Mitogen‐activated protein kinase kinase inhibitors have shown promising results in treatment of plexiform neurofibromas in neurofibromatosis type 1 patients, but data in adults are limited. The aim of this phase 2 study was to investigate the efficacy and safety of trametinib in adults with neurofibromatosis type 1.
D. Christine Noordhoek, David F. Hanff, Pim J. French, Sarah A. van Dijk, Erik A.C. Wiemer, Olivier C. Manintveld, Martin J. van den Bent, Walter Taal   +7 more
wiley   +1 more source

Safety and efficacy of levetiracetam for the treatment of partial onset seizures in children from one month of age

Neuropsychiatric Disease and Treatment, 2013
Justine Cormier, Catherine J ChuMassachusetts General Hospital, Department of Neurology, Programs in Child Neurology and Neurophysiology, Boston, MA, USAAbstract: Epilepsy is a common neurological disorder in the pediatric population, affecting up to one
Cormier J, Chu CJ
doaj  

WITHDRAWN: Oxcarbazepine add-on for drug-resistant partial epilepsy. [PDF]

Cochrane Database Syst Rev, 2016
Castillo SM, Schmidt DB, White S, Shukralla A.   +3 more
europepmc   +1 more source

Dynamic Susceptibility Contrast (DSC) MRI and Interictal Epileptiform Activity in Cryptogenic Partial Epilepsy [PDF]

, 2002
Fabio Placidi, Roberto Floris, Alessandro Bozzao, Andrea Romigi, Mario Tombini, Maria Elena Baviera, Francesca Sperli, Francesca Izzi, Donatella Mattia, Maria Grazia Marciani   +9 more
openalex   +1 more source